Condition
Head and Neck Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Head and Neck Tumors clinical trials that are recruiting, at sites in 4 countries (most in China (5), Germany (1), United States (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 4Countries
Newest Head and Neck Tumors clinical trials
All recruiting trials (8)
-
SI-B036 in head and neck and other solid tumors: a first-in-human study
This early-phase study tests SI-B036 in adults with locally advanced or metastatic head and neck cancers and other solid tumors to see if it is safe and tolerable, and to get initial clues about its activity.
-
LRRC15-targeted PET imaging for more precise diagnosis and staging of pancreatic, breast, lung, sarcoma and head-and-neck cancers
This project tests whether an LRRC15-targeted PET scan can better detect and stage LRRC15-expressing cancers and measures how the tracer behaves in healthy adults.
-
Understanding metal elements in radiation-induced mouth sores
This study is trying to see if certain metal elements in the body can help predict how severe mouth sores will be for patients getting radiation treatment for head and neck cancer.
-
Understanding how mutant p53/YAP proteins affect treatment resistance in head and neck cancer
This study looks at how changes in certain proteins in head and neck cancer cells might make them resistant to treatment, helping doctors find better ways to fight the disease.
-
Using breath analysis to predict mouth sores from radiotherapy in head and neck cancer patients
This study is testing whether analyzing breath samples can help predict mouth sores in head and neck cancer patients receiving radiotherapy.
-
Targeted alpha therapy [212Pb]VMT-Alpha-NET for SSTR-positive metastatic or inoperable GI neuroendocrine, pheochromocytoma/paraganglioma, small cell lung, kidney, and head & neck cancers
This trial will try an experimental targeted alpha-particle drug called [212Pb]VMT-Alpha-NET in adults whose metastatic or inoperable tumors show somatostatin receptor (SSTR) expression.
-
Combining tislelizumab with chemotherapy for advanced head and neck tumors
This study is testing if combining a new immune treatment called tislelizumab with chemotherapy can help people with advanced head and neck tumors feel better and improve their treatment outcomes.
-
Improving surgical guidance for head and neck tumor treatment
This study is testing a new way to help doctors remove head and neck tumors more accurately during surgery to improve treatment for patients with certain types of cancer.
Related topics
Quick answers
How many Head and Neck Tumors clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (5 trials), Germany (1 trial), United States (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.